Health Care Facilities

BAYZED HEALTH

BAYZED HEALTH released FY2025 9 Months Earnings on March 31 (BJT), actual revenue HKD 920.24 M, actual EPS HKD -0.0163

BAYZED HEALTH released FY2025 Q4 earnings on March 31, 2026 (BJT), actual revenue HKD 303.09 M, actual EPS HKD 0.0064

BAYZED HEALTH released FY2025 Annual Earnings on March 31, 2026 (BJT), with actual revenue of HKD 1.224 B and EPS of HKD -0.0109

BAYZED HEALTH released FY2025 Q3 earnings on March 31, 2026 (BJT) with actual revenue of HKD 297.95 M and EPS of HKD 0.0062

Brightze Medical Announces Annual Results for the Year Ended December 31, 2025

BAYZED HEALTH to Release FY2025 Earnings Report on March 31, 2026 (BJT)

BPA Medical Holdings Shareholder Deposits HKD 289 Million in CITIC Securities Brokerage Hong Kong

BAYZED HEALTH released FY2025 Q2 earnings on August 26, 2025 (BJT) with actual revenue of HKD 314.53 M and EPS of HKD -0.0114

BAYZED HEALTH released FY2025 Q1 earnings on August 26, 2025 (BJT) with actual revenue of HKD 307.76 M and EPS of HKD -0.0112

BAYZED HEALTH released FY2025 Semi-Annual earnings on August 26, 2025 (BJT) with actual revenue of HKD 622.29 M and EPS of HKD -0.0226

BAYZED HEALTH to Release FY2025 Semi-Annual Earnings on August 26, 2025 (BJT)

Taiyuan Peace Hospital Publishes 'Expert Consensus on Tumor Rehabilitation'

Baison Healthcare's stock hits a new high

Baise Medical's IPO sees strong price increase

Brightze Medical's dark pool trading price rises

Bayzed Health Group Successfully Listed with Acquisition-driven Expansion

BAYZED HEALTH released FY2024 Annual Earnings on June 12, 2025 (BJT) with actual revenue of HKD 1.287 B and EPS of HKD -0.0122

BAYZED HEALTH released FY2024 Q3 earnings on June 12, 2025 (BJT) with actual revenue of HKD 342.46 M and EPS of HKD -0.0008

BAYZED HEALTH released FY2023 Annual Earnings on June 12, 2025 (BJT) with actual revenue of HKD 1.177 B and EPS of HKD -0.0244

BAYZED HEALTH released FY2024 Q4 earnings on June 12 (BJT), actual revenue HKD 328.68M, actual EPS HKD -0.0008

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

02609

159929

516820

At yesterday's close, BAYZED HEALTH had a trading volume of approximately HKD 45.49 million, showing relatively active performance among small and mid-cap medical stocks. The MACD daily line has shown bullish signals above the zero axis, and the short-term moving averages are turning upwards, which is typically interpreted by the market as a confirmation signal of a phase upward trend, indicating that buying power is quietly recovering. Recently, BAYZED HEALTH's performance has gradually emerged from the bottom consolidation range, with moderate volume expansion indicating that funds are positioning at lower levels. On the news front, the Hong Kong stock market's pharmaceutical sector has recently shown a divergence in performance, with Innovent Biologics surging 6.01% yesterday, and 3SBio rising 4.14%, while the innovative drug sub-sector has attracted active capital. Leading CXOs like BeiGene and WuXi Biologics have shown relatively weak performance, with clear rotation characteristics within the sector. As a participant in the healthcare services field, BAYZED HEALTH benefits from the long-term logic of sustained growth in domestic healthcare demand. In April, the PMI service index was 49.6%, slightly below the boom-bust line, but healthcare services, as a necessity, are relatively less affected by economic cycle fluctuations. At the same time, the Federal Reserve's policy tone of maintaining interest rates has somewhat alleviated the pressure of capital outflow, which is beneficial for stabilizing the valuations of small and mid-cap stocks in the Hong Kong market. From a technical perspective, the bullish signals above the zero axis provide directional reference, but the current trading volume level remains moderate. To further confirm the upward trend, sustained volume support is needed. Today, attention should be paid to the overall capital flow in the pharmaceutical sector and whether this stock can maintain active buying interest during the trading session. The divergent performance of the innovative drug and healthcare services sub-sectors will influence the direction of capital allocation

Technical Forecast

China Universal 800 Health Care ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Bosera Hang Seng Health Care ETF(QDII)

Tianhong CNI BIOMEDICINE ETF

E Fund CSI 300 Health Care ETF

ICBCCS SSE STAR Biology and Medicine ETF

Dacheng CSI All Share Health Care Equipment and Services ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Penghua SSE STAR Biology and Medicine ETF

Penghua CSI HK Connect Health Care Composite ETF

Guotai CSI Bio-medicine ETF

Huaan Hang Seng Biotech ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

INNOVENT BIO

3SBIO

BeOne Medicines

BEONE MEDICINES

Beigene

WUXI BIO

Sunshine Guojian Pharmaceutical

WuXi Biologics

Pre-market trend | BAYZED HEALTH (2609.HK) Short-term bulls emerge on April 30, is there an undercurrent in the healthcare sector?

06636

00100

Hong Kong stock market overview in the past hour Market sentiment seems to be gradually warming up amid recent fluctuations, especially with strong performances in the healthcare and technology sectors. Capital flows are clearly favoring small-cap stocks and emerging industries, with short-term enthusiasm rising, driving overall gains. BAYZED HEALTH's strong surge has attracted market attention, and other related stocks have also become active, creating a positive linkage effect. Overall, stocks with significant gains are mostly concentrated in the pharmaceutical and technology sectors, indicating investors' preference for these areas. The stock with the largest movement in the past hour, BAYZED HEALTH, surged 20.20%, becoming the market focus. The stock quickly rose in the early trading phase, attracting a large influx of capital, with short-term sentiment running high, driving subsequent buying. The market's optimistic expectations for its future development seem to provide strong support. Strong stocks 1. EXTREME VISION: up 15.63%, recent market attention on its technological innovations has increased, with noticeable capital inflow. 2. MINIMAX-W: up 15.33%, active short-term capital, with market sentiment high, driving rapid price increases. 3. FLOWING CLOUD: up 15.29%, performing well driven by technology stocks, attracting considerable short-term capital. 4. LEPU BIO-B: up 15.17%, strong performance in the pharmaceutical sector supports its stock price's continuous rise. 5. CIFI HOLD GP: up 15.15%, with optimistic expectations for its future performance, capital continues to flow in

HK Stock Alerts

EXTREME VISION

MINIMAX-W

FLOWING CLOUD

LEPU BIO

CIFI HOLD GP

ONEROBOTICS

LEADS BIOLABS-B

LINGBAO GOLD

COSCO SHIP ENGY

TONGGUAN GOLD

Hong Kong Stock Movement Update: The medical technology sector rebounds strongly, BAYZED HEALTH surges 20% to lead the gains!

08368

00399

09995

The market overview of Hong Kong stocks in the past hour shows significant fluctuations in market sentiment, with a clear divergence in capital flows. Technology and pharmaceutical stocks have become hotspots for capital chasing, especially the strong rise of STARCOIN GROUP, which has attracted a lot of short-term capital attention. Meanwhile, some individual stocks like CREATIVE CHINA have encountered sharp declines, indicating a strong differentiation in the market. Overall, short-term enthusiasm is high, with increased volatility, and investor sentiment seems to be continuously adjusting. 

In the past hour, the stock with the most significant movement is STARCOIN GROUP, which performed impressively, with an increase of 24.76%, repeatedly hitting the upper limit during the session, showing strong buying sentiment. The rapid inflow of funds has attracted numerous investors' attention to this stock in a short period, boosting the activity of related sectors. 

Strong stocks:
1. BAYZED HEALTH: up 16.75%, with recent market attention on its product line, short-term capital actively intervening.
2. JINXUN RESOURCE: up 15.78%, benefiting from rising resource prices, with market sentiment high and noticeable capital inflow.
3. MINIMAX-W: up 15.33%, with active short-term trading attracting participation from speculative funds.
4. INSILICO: up 12.05%, with a strengthening technical outlook and optimistic market sentiment regarding its future development prospects.
5. EPIWORLD: up 11.52%, with the company's recent earnings forecast sparking market discussions and rapid capital follow-up.
6. REMEGEN: up 11.17%, with the overall biotechnology sector strengthening, driving this stock's rise

CREATIVE CHINA

STARCOIN GROUP

JINXUN RESOURCE

INSILICO

EPIWORLD

REMEGEN

DONGFANG ELEC

ILUVATAR COREX

Hong Kong Stock Movement Update: STARCOIN GROUP surges 24.76%, CREATIVE CHINA plummets 26.32%

00658

02665

01872

02889

06821

06687

01519

01415

00290

C TRANSMISSION(00658) rose 31.76%, with a trading turnover 11.4 Million HKD, and a year-to-date rose 19.6%. SEYOND(02665) rose 28.25%, with a trading turnover 107.5 Million HKD, and a year-to-date fell 9%. GUAN CHAO HLDGS(01872) rose 19.86%, with a trading turnover 25.2 Million HKD, and a year-to-date fell 5.8%.

Top Gainers&Losers

C TRANSMISSION

SEYOND

GUAN CHAO HLDGS

PATEO

Asymchem

JST GROUP

J&T EXPRESS-W

COWELL

GOFINTECH QUANT

Top 10 HK Stock Gainers (3.31)

Bayzed Health Extends RMB188 Million in Loans and Guarantees to Partner Hospital

Tip Ranks

Bayzed Health Extends RMB188 Million in Loans and Guarantees to Partner Hospital

02617

02618

02315

01757

09860

00467

01866

01060

TRANSTHERA-B(02617) rose 43.53%, with a trading turnover 2.6 Billion HKD, and a year-to-date fell 19.9%. JD LOGISTICS(02618) rose 22.98%, with a trading turnover 1.4 Billion HKD, and a year-to-date rose 10.6%. BIOCYTOGEN-B(02315) rose 20.96%, with a trading turnover 142.6 Million HKD, and a year-to-date rose 54.8%.

TRANSTHERA-B

JD LOGISTICS

BIOCYTOGEN-B

GLOBAL CHI BC

ADICON HOLDINGS

UNITEDENERGY GP

CHINA XLX FERT

DAMAI ENT

Top 10 HK Stock Gainers (3.6)

On February 3rd, BAYZED HEALTH (2609.HK) maintained a low-volume oscillation throughout the day, with the bottom consolidation pattern still in place. The medical services sector lacked favorable policies this week, and mainstream funds are generally waiting for more definitive guidance. Short-term focus is on whether the bottom consolidation area can attract support, with some funds testing low absorption during the session. Technical indicators are also weak, with the daily MACD death cross signal continuing to amplify and the KDJ approaching the oversold area. Intraday trading is mainly characterized by rotation within existing positions, with major funds not significantly increasing their holdings, resulting in sluggish trading. There is heated discussion in the community about potential catalysts from upcoming new mergers or cooperation events, but previous small cooperation news has already been largely digested. Operational advice: If intraday volume surges or significant industry news materializes, a short-term rebound may be initiated; otherwise, weak consolidation will dominate. Observers can continue to track bottom fund behavior and anomalies, and short-term risk management should be prioritized to strictly control loss exposure. Only when the market shows signs of warming can one consider positioning for a right-side trend

Morning Trend | BAYZED HEALTH is building a bottom and consolidating, is a low-level fluctuation and intraday movement coming?

00108

01057

02208

00917

06069

06086

01815

09966

06181

GR LIFE STYLE(00108) fell 12.74%, with a trading turnover 5.0 Million HKD, and a year-to-date rose 186.1%. ZHEJIANG SHIBAO(01057) fell 11.45%, with a trading turnover 246.3 Million HKD, and a year-to-date rose 70%. GOLDWIND(02208) fell 10.99%, with a trading turnover 1.0 Billion HKD, and a year-to-date rose 111.7%.

GR LIFE STYLE

ZHEJIANG SHIBAO

GOLDWIND

QUNABOX GROUP

SY HOLDINGS

FANGZHOU JIANKE

EVEREST GOLD

ALPHAMAB-B

LAOPU GOLD

Top 10 HK Stock Losers (12.30)

Bayzed Health Group (HKG:2609) has a solid balance sheet with CN¥410.6m in net cash, as it holds CN¥835.2m in cash against CN¥424.6m in debt. Despite a 10% decline in EBIT over the past year, the company has converted 478% of EBIT to free cash flow, totaling CN¥137m. This indicates a strong capacity to manage its debt, although the decline in earnings is a concern. Overall, the company's financial position appears stable, making it less risky in terms of debt management.

Simplywall

Bayzed Health Group (HKG:2609) Has A Pretty Healthy Balance Sheet

BAYZED HEALTH(02609.HK)

Pre-market trend | BAYZED HEALTH (2609.HK) Short-term bulls emerge on April 30, is there an undercurrent in the healthcare sector?

Hong Kong Stock Movement Update: The medical technology sector rebounds strongly, BAYZED HEALTH surges 20% to lead the gains!

Hong Kong Stock Movement Update: STARCOIN GROUP surges 24.76%, CREATIVE CHINA plummets 26.32%

Top 10 HK Stock Gainers (3.31)

Bayzed Health Extends RMB188 Million in Loans and Guarantees to Partner Hospital

Top 10 HK Stock Gainers (3.6)

Morning Trend | BAYZED HEALTH is building a bottom and consolidating, is a low-level fluctuation and intraday movement coming?

Top 10 HK Stock Losers (12.30)

Bayzed Health Group (HKG:2609) Has A Pretty Healthy Balance Sheet